UNIVERSITY OF WASHINGTON
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics is a funding opportunity from UNIVERSITY OF WASHINGTON, up to 671529, closing July 31, 2026.
Jul 31, 2026
(0d left)Overview
PROJECT SUMMARY One of the most pressing public health priorities for the COVID-19 pandemic is the development of an effective and inexpensive therapeutic. The long-term goal of this proposal is to develop such COVID-19 treatments, as well as the methods needed to rapidly create such molecules as soon as any new…